EU_TED process · buyer country DEU · award
Abschluss eines nicht-exklusiven Rabattvertrages gemäß§ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
['IKK classic']
EUR 1
Data last updated Oct 22, 2026 · Source: Tenders Electronic Daily
- Buyer
- ['IKK classic']
- Buyer identifier
- TED_ORGANISATION: 993-80175-34
- Primary supplier
- ['Abacus Medicine', 'Originalis B.V.']
- Procurement method
- Not reported
- Tender deadline
- Not reported
- Contract period
- Not reported — Not reported
- Native value
- EUR 1
- USD comparison
- Not shown — no auditable FX observation
- Official source
- Open notice ↗
Description
Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx (Wirkstoff: Bimekizumab, ATC-Code: L04AC21, Vertragslaufzeit: 01.10.2026-30.09.2028)
Suppliers
- ['Abacus Medicine', 'Originalis B.V.'] · primary
Official lifecycle
Process timeline
- Award announced
Abschluss eines nicht-exklusiven Rabattvertrages gemäß§ 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx
Notice versions
| Publication | Version | Type | Date | Source |
|---|---|---|---|---|
| 763593-2026 | 1 | can-standard | Nov 3, 2026 | Official notice ↗ · XML ↗ |
Lots
| Lot | CPV | Performance | NUTS | Value |
|---|---|---|---|---|
| LOT-0000 | 33600000, 33600000 | DEU | DED21 | Not reported |
Contracts
| Contract | Lot | Status | Period | Value |
|---|---|---|---|---|
| Abschluss eines nicht-exklusiven Rabattvertrages gemäß § 130c Abs. 1 SGB V zwischen der IKK classic und Abacus Medicine und Originalis B.V. zu Bimzelx | LOT-0000 | Not reported | Not reported — Not reported | Not reported |
Auditable model output
Predictive intelligence
Append-only source history
Source records
| Record | Date | Stages | Fetched |
|---|---|---|---|
| 3f2ce9a6-42ef-4f31-a8fc-d56f0174b61d:1 | Nov 3, 2026 | award_announced | Nov 3, 2026 |